Proteoglycans in Lung Disease

Discusses new treatment strategies for malignant mesothelioma, pulmonary edema, fibrosis, asthma, emphysema, and bronchiectasis.

Proteoglycans in Lung Disease considers

glycosaminoglycans as novel therapeutic agents or targets in lung disease

the role of proteoglycans in determining mechanical behavior of lung tissue

hyaluronan and its receptors in wound healing, inflammation, vasculogenesis, and angiogenesis

the impact of small proteoglycans on matrix assembly

versican as a modulator of cell adhesion, migration, and proliferation

antiproliferative activity of heparin and its derivatives on pulmonary artery smooth muscle cells

the effects of mechanical strain on proteoglycans

the functions of proteoglycans in the vascular wall

the effect of hypoxia on glycosaminoglycans in the lung

Comprised of more than 1940 references, Proteoglycans in Lung Disease